We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LYRA market cap is 12.55M. The company's latest EPS is USD -0.9576 and P/E is -0.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 544k | 146k | 532k | 598k | 195k |
| Operating Income | -16.83M | -18.07M | -23.52M | -26.14M | -12.44M |
| Net Income | -15.65M | -15.16M | -22.45M | -48.13M | -11.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 285k | 1.36M | 1.56M |
| Operating Income | -16.52M | -22.21M | -43.62M | -56.31M | -67.12M |
| Net Income | -16.31M | -22.13M | -43.51M | -55.28M | -62.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 120.58M | 142.6M | 141.53M | 94.58M | 78.76M |
| Total Liabilities | 36.34M | 53.18M | 64.02M | 63.61M | 58.14M |
| Total Equity | 84.24M | 89.42M | 77.5M | 30.98M | 20.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.96M | 80.83M | 54.87M | 109.97M | 142.6M |
| Total Liabilities | 7.64M | 6.34M | 20.55M | 29.21M | 53.18M |
| Total Equity | -123.34M | 74.49M | 34.32M | 80.75M | 89.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.25M | -63.3M | -22.46M | -42.44M | -58.66M |
| Investing | -10.23M | -12.58M | 7.86M | 44.03M | 52.17M |
| Financing | 46.77M | 65.69M | 8.64M | 8.56M | 8.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.75M | -21.14M | -25.82M | -43.39M | -63.3M |
| Investing | -211k | -1.78M | -3.39M | -65.01M | -12.58M |
| Financing | -115k | 87.7M | 359k | 96.26M | 65.69M |
| Market Cap | 12.55M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 7.98 |
| Price to Cash Ratio | 0.56 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 65.46M |
| Average Volume (1 week) | 1.26M |
| Average Volume (1 Month) | 1.4M |
| 52 Week Change | -96.29% |
| 52 Week High | 6.79 |
| 52 Week Low | 0.1625 |
| Spread (Intraday) | 0 (1.45%) |
| Company Name | Lyra Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://lyratherapeutics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
